🇯🇵 Vyndaqel in Japan

Vyndaqel (Tafamidis Meglumine) regulatory status in Japan.

Marketing authorisations

PMDA

  • Application: Vyndaqel Initial Approval
  • Local brand name: Vyndaqel Initial Approval
  • Status: approved

Read official source →

PMDA

  • Application: Vyndaqel Partial Change Approval
  • Local brand name: Vyndaqel Partial Change Approval
  • Status: approved

Read official source →

Vyndaqel in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Japan

Frequently asked questions

Is Vyndaqel approved in Japan?

Yes. PMDA has authorised it; PMDA has authorised it.

Who is the marketing authorisation holder for Vyndaqel in Japan?

Foldrx Pharms is the originator. The local marketing authorisation holder may differ — check the official source linked above.